Further analysis revealed that YAP depletion and verteporfin treatment attenuated the transcription of TEAD target genes, such as AREG, CTGF, and CYR61, all of which are associated with diverse tumor-promoting activities, including enhanced metastatic potential and cancer cell proliferation (Fig. 2D, S5) [28]. The gene discussed is CCN2; the disease is cancer.